Baxdrostat, Dapagliflozin Placebo, Forxiga 10 mg film-coated tablets
D6972C00006
Phase 2 small_molecule active
Quick answer
Baxdrostat, Dapagliflozin Placebo, Forxiga 10 mg film-coated tablets for Chronic kidney disease (CKD) and hypertension. is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Chronic kidney disease (CKD) and hypertension.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active